IN2014MU00195A - - Google Patents

Info

Publication number
IN2014MU00195A
IN2014MU00195A IN195MU2014A IN2014MU00195A IN 2014MU00195 A IN2014MU00195 A IN 2014MU00195A IN 195MU2014 A IN195MU2014 A IN 195MU2014A IN 2014MU00195 A IN2014MU00195 A IN 2014MU00195A
Authority
IN
India
Prior art keywords
compound
formula
preparation
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Sanjeev Joshi
Sunil Bhaginath Jadhav
Vipul Rane
Satish Bhawsar
Prasad Keshav Deshpande
Ravindra Dattatraya Yeole
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/067377 priority Critical patent/WO2015110885A1/en
Priority to IN195MU2014 priority patent/IN2014MU00195A/en
Priority to EP14837077.8A priority patent/EP3105231A1/en
Priority to US15/108,296 priority patent/US9771364B2/en
Publication of IN2014MU00195A publication Critical patent/IN2014MU00195A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IN195MU2014 2014-01-21 2014-12-29 IN2014MU00195A (enExample)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/IB2014/067377 WO2015110885A1 (en) 2014-01-21 2014-12-29 A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
IN195MU2014 IN2014MU00195A (enExample) 2014-01-21 2014-12-29
EP14837077.8A EP3105231A1 (en) 2014-01-21 2014-12-29 A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
US15/108,296 US9771364B2 (en) 2014-01-21 2014-12-29 Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN195MU2014 IN2014MU00195A (enExample) 2014-01-21 2014-12-29

Publications (1)

Publication Number Publication Date
IN2014MU00195A true IN2014MU00195A (enExample) 2015-08-28

Family

ID=52478023

Family Applications (1)

Application Number Title Priority Date Filing Date
IN195MU2014 IN2014MU00195A (enExample) 2014-01-21 2014-12-29

Country Status (4)

Country Link
US (1) US9771364B2 (enExample)
EP (1) EP3105231A1 (enExample)
IN (1) IN2014MU00195A (enExample)
WO (1) WO2015110885A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013380574B2 (en) 2013-03-08 2016-07-07 Wockhardt Limited A process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane
KR20200030584A (ko) 2017-07-21 2020-03-20 앤타바이오 에스에이에스 화합물
US11180501B2 (en) 2017-12-01 2021-11-23 Qilu Pharmaceutical Co., Ltd. Crystal form of β-lactamase inhibitor and preparation method therefor
EP3572411A1 (en) 2018-05-21 2019-11-27 Antabio SAS Thiazole derivatives as metallo-beta-lactamase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013028813B1 (pt) * 2011-08-27 2020-10-20 Wockhardt Limited derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e composições farmacêuticas que os compreendem
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
WO2014135931A1 (en) 2013-03-08 2014-09-12 Wockhardt Limited A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane

Also Published As

Publication number Publication date
EP3105231A1 (en) 2016-12-21
WO2015110885A1 (en) 2015-07-30
US20160340359A1 (en) 2016-11-24
US9771364B2 (en) 2017-09-26

Similar Documents

Publication Publication Date Title
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
NZ726356A (en) Processes for preparing antiviral compounds
GR20140100479A (el) Συνθεση λιραγλουτιδης
AU2016277367A8 (en) Aryl sulfonohydrazides
IN2014CH00247A (enExample)
MX2017002214A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
MX2016010973A (es) Compuestos de aminocarbonilcarbamato.
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
TW201613871A (en) Process for the preparation of 5-fluoro-1H-pyrazoles starting from hexafluoropropene
IN2014MU01192A (enExample)
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
MX382659B (es) Proceso para la preparación de derivados de tiazol.
IN2014MU00194A (enExample)
IN2014MU01196A (enExample)
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.
MX380240B (es) Preparación de piperidin-4-carbotioamida.
MX364769B (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
IN2014CH00444A (enExample)
IN2014MU00858A (enExample)
IN2014MU01195A (enExample)
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos